CTC PD-L1 assay enables longitudinal monitoring of PD-L1 status in lung cancer patients and may help to advance personalised treatment GUILDFORD, UNITED KINGDOM / ACCESSWIRE / November 15, 2024 / ...

Biofidelity, a leader in innovative genomic solutions, today announced the launch of Aspyre Lung Reagents (research use only) for liquid biopsy samples. Aspyre Lung identifies established non-small ...

New analysis from the DETECT-A study supports MCED testing as a complement to current guideline-recommended screening in lung ...

A 41-year-old Dunwoody mom who never smoked a day in her life was diagnosed with terminal stage 4 lung cancer.

The Ion Robotic Navigational Bronchoscopy system is minimally invasive and can identify cancer in even the smallest lung nodules.

Anchor] Korean researchers have developed a technology that can diagnose lung cancer early using genetic scissors.It is the ...

A breakthrough AI-powered liquid biopsy combining cell-free DNA and protein biomarkers improves early detection of ovarian ...

Medically reviewed by Susan Russell, MDLung cancer prognosis tends to be better for people diagnosed in earlier stages of the ...

New study introduces a simple blood test to detect early lung damage in cancer patients receiving novel ... University ...

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday.

ARP Atlases. 2007;1:17-47. The total number of leukocytes recovered by lavage is determined by examination of a sample of the pooled fluid with a hemocytometer. The cell counts are most accurate ...